118 related articles for article (PubMed ID: 10025097)
21. Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.
Roos H; Dahlberg L; Hoerrner LA; Lark MW; Thonar EJ; Shinmei M; Lindqvist U; Lohmander LS
Osteoarthritis Cartilage; 1995 Mar; 3(1):7-14. PubMed ID: 7719956
[TBL] [Abstract][Full Text] [Related]
22. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis.
Witter J; Roughley PJ; Webber C; Roberts N; Keystone E; Poole AR
Arthritis Rheum; 1987 May; 30(5):519-29. PubMed ID: 2439090
[TBL] [Abstract][Full Text] [Related]
23. Serum keratan sulfate is a promising marker of early articular cartilage breakdown.
Wakitani S; Nawata M; Kawaguchi A; Okabe T; Takaoka K; Tsuchiya T; Nakaoka R; Masuda H; Miyazaki K
Rheumatology (Oxford); 2007 Nov; 46(11):1652-6. PubMed ID: 17855425
[TBL] [Abstract][Full Text] [Related]
24. Cartilage markers in synovial fluid in symptomatic knee osteoarthritis.
Petersson IF; Sandqvist L; Svensson B; Saxne T
Ann Rheum Dis; 1997 Jan; 56(1):64-7. PubMed ID: 9059144
[TBL] [Abstract][Full Text] [Related]
25. Chondroitin sulfate and joint disease.
Hardingham T
Osteoarthritis Cartilage; 1998 May; 6 Suppl A():3-5. PubMed ID: 9743812
[TBL] [Abstract][Full Text] [Related]
26. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
Ratcliffe A; Beauvais PJ; Saed-Nejad F
J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
[TBL] [Abstract][Full Text] [Related]
27. Dermatan sulfate in the synovial fluid of patients with knee osteoarthritis.
Momohara S; Okada N; Ikari K; Mizuno S; Okamoto H
Mod Rheumatol; 2007; 17(4):301-5. PubMed ID: 17694263
[TBL] [Abstract][Full Text] [Related]
28. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
29. Ageing of equine articular cartilage: structure and composition of aggrecan and decorin.
Platt D; Bird JL; Bayliss MT
Equine Vet J; 1998 Jan; 30(1):43-52. PubMed ID: 9458398
[TBL] [Abstract][Full Text] [Related]
30. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
31. [Role of aggrecanase and MMP in cartilage degradation].
Ishiguro N; Kojima T
Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
[TBL] [Abstract][Full Text] [Related]
32. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
[TBL] [Abstract][Full Text] [Related]
33. Markers of joint tissue turnover in joint fluids from hips with osteonecrosis of the femoral head.
Jingushi S; Lohmander LS; Shinmei M; Hoerrner LA; Lark MW; Sugioka Y; Iwamoto Y
J Orthop Res; 2000 Sep; 18(5):728-33. PubMed ID: 11117293
[TBL] [Abstract][Full Text] [Related]
34. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
35. Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.
Heinegård D
Int J Exp Pathol; 2009 Dec; 90(6):575-86. PubMed ID: 19958398
[TBL] [Abstract][Full Text] [Related]
36. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood.
Saxne T; Heinegård D
Br J Rheumatol; 1992 Sep; 31(9):583-91. PubMed ID: 1381980
[TBL] [Abstract][Full Text] [Related]
37. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
[TBL] [Abstract][Full Text] [Related]
38. UDP-D-xylose: proteoglycan core protein beta-D-xylosyltransferase: a new marker of cartilage destruction in chronic joint diseases.
Kleesiek K; Reinards R; Okusi J; Wolf B; Greiling H
J Clin Chem Clin Biochem; 1987 Aug; 25(8):473-81. PubMed ID: 3121782
[TBL] [Abstract][Full Text] [Related]
39. Synovial fluid analyses detect and differentiate proteoglycan metabolism in canine experimental models of osteoarthritis and disuse atrophy.
Ratcliffe A; Beauvais PJ; Saed-Nejad F; Shurety W; Caterson B
Agents Actions Suppl; 1993; 39():63-7. PubMed ID: 8456644
[TBL] [Abstract][Full Text] [Related]
40. The extended family of proteoglycans: social residents of the pericellular zone.
Gallagher JT
Curr Opin Cell Biol; 1989 Dec; 1(6):1201-18. PubMed ID: 2517581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
